Dronabinol Safe and Effective for Neuropathic Pain Associated With Multiple Sclerosis
Pain intensity was not significantly reduced by dronabinol, compared with placebo after 16 weeks of treatment.
Peripheral nerve stimulation may provide long-term pain relief in patients with painful mononeuropathy secondary to leprosy.
After 5 years, 55% of patients had experienced treatment success and 80% of patients with a permanent implant still used their SCS device.
Acupuncture may reduce pain intensity and mechanical thresholds in patients with idiopathic trigeminal neuralgia.